On Friday, FDA granted an emergency use authorization (EUA) to a second COVID-19 vaccine—Moderna’s mRNA COVID-19 vaccine, which is indicated for individuals ages 18 years and older. 

The Trump administration has pledged fast and fair distribution of Eli Lilly's newly sanctioned COVID-19 treatment, but tight supply and logistical barriers will present a challenge.